vimarsana.com

Latest Breaking News On - Imaging biometric - Page 1 : vimarsana.com

IQ-AI software installed by Swiss hospital group

IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF) s subsidiary, Imaging Biometrics, has successfully installed its advanced imaging software at Insel Gruppe AG, a hospital.

IQ-AI subsidiary wins FDA designation for lead drug candidate

IQ-AI subsidiary wins FDA designation for lead drug candidate
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

IQ-AI advances glioblastoma clinical trial, eyes phase two in 2025

IQ-AI advances glioblastoma clinical trial, eyes phase two in 2025
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

IQ-AI advances glioblastoma clinical trial, eyes phase two in 2025

Dr Jennifer Connelly, MD, the Principal Investigator (PI) of the IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF) sponsored phase one clinical trial that is being.

IQ-AI shares sink on discounted placing fundraise

IQ-AI Ltd - Medical services firm and parent company of Wisconsin-based healthcare imaging software firm Imaging Biometrics LLC - Announces placing to raise GBP300,000 gross proceeds via the issue of.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.